Publisher
Springer International Publishing
Reference17 articles.
1. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down’s syndrome: an international collaborative study. Genet Med. 2012;14:296–305.
2. NHS Fetal anomaly screening programme Annual Report. NHS FASP April 2010-March 2011. London: UK National Screening Programmes Directorate, 2011.
3. Ward P, Soothill P. Fetal anomaly ultrasound scanning: the development of a national screening programme for England. Obstet Gynaecol. 2011;13:211–7.
4. Khalil A, Mahmoodian N, Kulkarni A, Homfray T, Papageorghiou A, Bhide A, Thilaganathan B. Estimation of detection rates of aneuploidy in high-risk pregnancy using an approach based on nuchal translucency and non-invasive prenatal testing: a cohort study. Fetal Diagn Ther. 2015;38(4):254–61.
5. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG. 2000;107:1271–5.